FDA Accepts Review of Samsung Bioepis and Biogen’s Ranibizumab Biosimilar
US Inventor, Inc. Moves to Prevent Any New AIA Reviews Until NHK-Fintiv is Corrected
Biocon Biologics and Mylan Announce U.S. Launch of Insulin Glargine Product Semglee
Silicon Valley Challenges the PTAB’s NHK-Fintiv Rule: Can IPRs Be Denied Based on Non-Statutory Factors?
Teva and Alvotech Announce Partnership in the U.S. Biosimilar Market
Patent Owners May Struggle to Get IPR Petitions Denied: Sand Revolution II, LLC v. Continental Intermodal Group – Trucking LLC
Delays, Denials and Uncertainty: Developments in the Arthrex Redo Case Line
Federal Circuit Denies Stay of Arthrex Remands: PTAB Must Start Working on Rehearings
